Thomas Peter Almdal

Thomas Peter Almdal serves as an Associate Professor at the Department of Immunology and Microbiology and holds a Clinical Associate Professor position at the Department of Clinical Medicine, both within the Faculty of Health and Medical Sciences at the University of Copenhagen.

• Institution: University of Copenhagen
• Primary Department: Department of Immunology and Microbiology
• Clinical Affiliation: Department of Clinical Medicine
• Location: Blegdamsvej 3B, 2200 København N, Denmark

Dr. Almdal's research program centers on diabetes complications across multiple organ systems, with particular expertise in cardiovascular complications in diabetic patients undergoing hemodialysis, metabolic aspects of cystic fibrosis, and long-term outcomes of lifestyle interventions in type 2 diabetes. His work bridges basic immunological research with clinical applications, reflecting his dual appointments.

Analysis of his 89 research outputs reveals a strong focus on clinical trials methodology and longitudinal cohort studies. His recent publications demonstrate expertise in designing and analyzing multicenter studies that address critical questions in diabetes management, particularly regarding glycemic control targets, cardiovascular risk assessment, and interventions for patients with comorbid conditions.

• Major ongoing studies include the CADDY study (cardiac complications in diabetic hemodialysis patients)
• DOSE-EX trial (exercise and caloric restriction in type 2 diabetes)
• U-TURN trial extension (long-term lifestyle intervention outcomes)
• Steno 1 study (multifactorial intervention for cardiovascular disease in type 1 diabetes)

Dr. Almdal maintains active collaborations with researchers across Danish medical institutions, particularly those affiliated with the Steno Diabetes Centre network. His work appears in high-impact journals including Diabetologia, Diabetes Care, and Journal of Sport and Health Science, reflecting the clinical relevance and methodological rigor of his research.